Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

Conditions:   Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate CancerInterventions:   Drug: Enzalutamide;   Drug: Goserelin acetate;   Drug: Leuprolide acetate;   Radiation: Radiation therapySponsors:   Thomas Jefferson University;   Astellas Pharma Inc;   Medivation, Inc.Recruiting - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials